HCTI (Healthcare Triangle) Research & Development: $0.48 Mil (TTM As of Mar. 2026)


HCTI Healthcare Triangle Inc HCTI
19 GF Score
Price $1.95
! 7 Warning Signs
View Full Analysis

What is Healthcare Triangle Research & Development?

Healthcare Triangle HCTI 19 Research & Development is $0.48 Mil as of Mar. 2026. GuruFocus rates HCTI with a GF Score™ of 19/100. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Healthcare Triangle's Research & Development for the three months ended in Mar. 2026 was $0.09 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.48 Mil.

Healthcare Triangle  (NAS:HCTI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Healthcare Triangle Research & Development Related Terms

Healthcare Triangle Research & Development Historical Data

* Premium members only.

The historical data trend for Healthcare Triangle's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare Triangle Research & Development Chart

Healthcare Triangle Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 5.26 8.14 0.80 0.43 0.54

Healthcare Triangle Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.06 0.06 0.28 0.09
HCTI
19GF Score
Healthcare Triangle Inc HCTI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthcare Triangle Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.48 Mil mean?
Healthcare Triangle (HCTI) has a Research & Development of $0.48 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Healthcare Triangle and its competitors.
Is Healthcare Triangle's Research & Development too high?
Healthcare Triangle's current Research & Development is $0.48 Mil. Overall, Healthcare Triangle has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Healthcare Triangle's Research & Development compare to MNDR and WLSS?
Healthcare Triangle's Research & Development of $0.48 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Healthcare Triangle and its competitors. Healthcare Triangle's current Research & Development is $0.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare Triangle stock overvalued right now?
Healthcare Triangle (HCTI) has a current Research & Development of $0.48 Mil. The current Research & Development is $0.48 Mil. Healthcare Triangle's overall GF Score™ is 19/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Healthcare Triangle (HCTI), the current Research & Development is $0.48 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Healthcare Triangle Business Description

Address 7901 Stoneridge Drive, Suite 210, Pleasanton, CA, USA, 94588
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their efforts to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Corporate & others.
19GF Score

Get the complete analysis for HCTI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.95
Price